The results of the landmark RE-COVER™ study
The RE-COVER™ trial results shed light on an important indication for anticoagulation: Acute Venous Thromboembolism.
The Boehringer Ingelheim Press Conferences chapter is the one-stop-shop for all information in connection with our press conferences and other media events.